TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35193638

Group type: EXPERIMENTAL
Intervention: multi-donor fecal microbiota (FM) transfer
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: multi-donor fecal microbiota filtrates (FMF) transfer
Number of subjects: 174

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 174
Study: 33373048

Group type: EXPERIMENTAL
Intervention: Tailored mental health literacy training for police members; leadership development and coaching program for station leaders.
Number of subjects: 53
Study: 32568876

Group type: EXPERIMENTAL
Intervention: 38°C forced-air warming blankets
Number of subjects: 123

Group type: COMPARATOR
Intervention: 43°C forced-air warming blankets
Number of subjects: 123
Study: 36102236

Group type: EXPERIMENTAL
Intervention: Moderate exacerbation
Number of subjects: 10355

Group type: EXPERIMENTAL
Intervention: Severe exacerbation
Number of subjects: 10355
Study: 32206786

Group type: EXPERIMENTAL
Intervention: 6-month regimen alternating intravenous and oral glucocorticoids with an alkylating agent every other month
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclical therapy (glucocorticoids and alkylating agent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcineurin inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mycophenolate salts and adrenocorticotropic hormone
Number of subjects: 0
Study: 34499904

Group type: EXPERIMENTAL
Intervention: Antibiotic group (3 g of ampicillin-sulbactam administered just before, 8 hours after, and the morning after ESD)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Nonantibiotic group (conventional treatment)
Number of subjects: 432
Study: 32746956

Group type: EXPERIMENTAL
Intervention: Revised Guided Questions Tool
Number of subjects: 82

Group type: COMPARATOR
Intervention: Original Guided Questions Tool
Number of subjects: 82
Study: 35206520

Group type: EXPERIMENTAL
Intervention: KEPT app
Number of subjects: 26

Group type: COMPARATOR
Intervention: Usual antenatal care (waitlist control)
Number of subjects: 26
Study: 33567185

Group type: EXPERIMENTAL
Intervention: Once-weekly subcutaneous semaglutide (2.4 mg)
Number of subjects: 1961

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1961
Study: 34811841

Group type: EXPERIMENTAL
Intervention: Basic Body Awareness Therapy (BBAT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 101
Study: 32279416

Group type: EXPERIMENTAL
Intervention: Circulating tumor DNA (ctDNA) allele frequency (AF)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: ctDNA AF, AFP level, and BCLC staging
Number of subjects: 73
Study: 36316511

Group type: EXPERIMENTAL
Intervention: Urea 40%
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fr Er:YAG laser
Number of subjects: 21
Study: 33180897

Group type: EXPERIMENTAL
Intervention: Alternative treatment options for hypertension (HTN)
Number of subjects: 2500000

Group type: EXPERIMENTAL
Intervention: Alternative treatment options for type II diabetes mellitus (T2DM)
Number of subjects: 2500000

Group type: EXPERIMENTAL
Intervention: Alternative treatment options for hyperlipidemia (HL)
Number of subjects: 2500000
Study: 32119883

Group type: EXPERIMENTAL
Intervention: Multiple Food Test (choice scale)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Multiple Food Test (applied knowledge scale)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Multiple Food Test (overall choices)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Multiple Food Test (subscales)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Health versus taste motive
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Self-control and habitual fruit and vegetable intake
Number of subjects: 666
Study: 33359303

Group type: EXPERIMENTAL
Intervention: Prophylactic hydrocortisone
Number of subjects: 325

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study: 32376724

Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg orally once daily) plus Camrelizumab (200 mg intravenously every 2 weeks)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Apatinib plus Camrelizumab
Number of subjects: 43
Study: 34878650

Group type: EXPERIMENTAL
Intervention: IL-1 receptor antagonist (Anakinra)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34063970

Group type: EXPERIMENTAL
Intervention: Wearable device + game-based virtual reality rehabilitation program (30 mins/session, 5 sessions/week, for 4 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 44
Study: 33185373

Group type: EXPERIMENTAL
Intervention: Paravertebral block using 25 mg bupivacaine plus 8 mg dexamethasone in a total volume of 10 mL twice one week apart (Group I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paravertebral block using 25 mg bupivacaine plus 8 mg dexamethasone in a total volume of 10 mL 3 times one week apart (Group II)
Number of subjects: 80
Study: 34996406

Group type: EXPERIMENTAL
Intervention: Liraglutide 3 mg daily injection
Number of subjects: 17
Study: 35590219

Group type: EXPERIMENTAL
Intervention: PF-06835919 300 mg
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: PF-06835919 75 mg
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 32981554

Group type: EXPERIMENTAL
Intervention: Shared decision making (SDM) intervention
Number of subjects: 305

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Coercive measures
Number of subjects: 305
Study: 35579454

Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 33542908

Group type: EXPERIMENTAL
Intervention: 18-22 mg/kg/d UDCA
Number of subjects: 73

Group type: COMPARATOR
Intervention: 13-15 mg/kg/d UDCA (standard dosage)
Number of subjects: 73
Study: 32548907

Group type: EXPERIMENTAL
Intervention: Associative conditioning with a positive peer context (group games paired with tasting target vegetables)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Repeated exposure (only taste exposures of target vegetables)
Number of subjects: 23
Study: 34556269

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 235

Group type: COMPARATOR
Intervention: No PCI (control)
Number of subjects: 235
Study: 33894583

Group type: EXPERIMENTAL
Intervention: Discrete Cosine Transform (DCT) model
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cosine model (CM)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: DCT model with amplitude variations from CBCTp
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: DCT model with baseline shift variability
Number of subjects: 66
Study: 32159454

Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Volumetric measurements
Number of subjects: 38
Study: 35485738

Group type: EXPERIMENTAL
Intervention: Breathing exercises via telemedicine (three times a day for 5 weeks, one session via telemedicine each week)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Breathing exercises via telemedicine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (brochure explaining exercises)
Number of subjects: 52
Study: 34837744

Group type: EXPERIMENTAL
Intervention: Bevacizumab (7.5 mg/kg) in combination with carboplatin (AUC 6) and paclitaxel (175 mg/m2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Carboplatin (AUC 6) and paclitaxel (175 mg/m2) without bevacizumab
Number of subjects: 80
Study: 32155323

Group type: EXPERIMENTAL
Intervention: Exercise intervention (multicomponent exercise training programme for 5-7 consecutive days, 2 sessions/day)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 370

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 370
Study: 35781044

Group type: EXPERIMENTAL
Intervention: Renal Denervation (RD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 80
Study: 33764278

Group type: EXPERIMENTAL
Intervention: Nursing approaches applied according to Meleis' Transition Theory
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 64
Study: 32334632

Group type: EXPERIMENTAL
Intervention: EM/AF + PF + PPC
Number of subjects: 0

Group type: COMPARATOR
Intervention: EM/AF
Number of subjects: 0
Study: 34920855

Group type: EXPERIMENTAL
Intervention: Uncuffed 3.5 mm ID tracheal tube
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cuffed 3.0 mm ID tracheal tube
Number of subjects: 30
Study: 33874974

Group type: EXPERIMENTAL
Intervention: VR based intervention along with standard treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard treatment after surgery (control group)
Number of subjects: 60
Study: 32571411

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) for 30 min at four acupoints, 4 times weekly for 12 weeks (total of 48 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no acupoint stimulation)
Number of subjects: 60
Study: 35089798

Group type: EXPERIMENTAL
Intervention: Second tertile of European ancestry proportion
Number of subjects: 2466

Group type: EXPERIMENTAL
Intervention: Third tertile of European ancestry proportion
Number of subjects: 2466

Group type: EXPERIMENTAL
Intervention: 5% point higher European ancestry
Number of subjects: 2466

Group type: COMPARATOR
Intervention: Intensive versus standard blood pressure treatment
Number of subjects: 2466
Study: 34131157

Group type: EXPERIMENTAL
Intervention: HIIT (3‐min intervals at 40% and 80% of oxygen uptake reserve, n = 18)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: MICT (sustained 60% of oxygen uptake reserve, n = 18)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (CTL, n = 18)
Number of subjects: 54
Study: 36329080

Group type: EXPERIMENTAL
Intervention: Micronutrients as nanoparticles (MN‐NPs) at a concentration of 40 mg/L
Number of subjects: 0

Group type: COMPARATOR
Intervention: Micronutrients as nanoparticles (MN‐NPs) at concentrations of 0, 10, 20, 30 mg/L
Number of subjects: 0
Study: 32250061

Group type: EXPERIMENTAL
Intervention: 1.5 mm subcrestally placed implants
Number of subjects: 32

Group type: COMPARATOR
Intervention: Epicrestally placed implants with 2 mm healing abutment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Subcrestal implant placement
Number of subjects: 32

Group type: COMPARATOR
Intervention: Soft tissue tenting
Number of subjects: 32
Study: 35441463

Group type: EXPERIMENTAL
Intervention: VAIA (vincristine, ifosfamide, adriamycin, dactinomycin)
Number of subjects: 557

Group type: COMPARATOR
Intervention: CEVAIE (carboplatin, epirubicin, vincristine, dactinomycin, ifosfamide, etoposide)
Number of subjects: 557
Study: 34196588

Group type: EXPERIMENTAL
Intervention: Guava leaf extract-menthol toner
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 35379638

Group type: EXPERIMENTAL
Intervention: HUC-MSCs administered intravenously at a dose of 1×10^6 cells/kg with a total volume of 100 mL diluted with normal saline through 120 mL/hour intravenous central line infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (normal saline) administered through 120 mL/hour intravenous central line infusion at the same quantity (total volume of 100 mL)
Number of subjects: 40
Study: 33942419

Group type: EXPERIMENTAL
Intervention: Patient-centred self-management programme
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 70
Study: 32530169

Group type: EXPERIMENTAL
Intervention: Maximal effort isokinetic knee exercises
Number of subjects: 200

Group type: COMPARATOR
Intervention: Half effort isokinetic knee exercises
Number of subjects: 200
Study: 37119361

Group type: EXPERIMENTAL
Intervention: RPE-guided training (n = 10; 2 female)
Number of subjects: 30
Study: 34441048

Group type: EXPERIMENTAL
Intervention: Lactoferrin treatment for seven days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group receiving approved Egyptian COVID-19 management protocol
Number of subjects: 54
Study: 35429525

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10 Hz; n = 7)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (1 Hz; n = 7)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both high-frequency and low-frequency rTMS
Number of subjects: 14
Study: 33287418

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Join the Healthy Boat programme
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 231
Study: 35396667

Group type: EXPERIMENTAL
Intervention: favipiravir treatment (early treatment group on day 1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: favipiravir treatment (late treatment group on day 6)
Number of subjects: 32
Study: 33674633

Group type: EXPERIMENTAL
Intervention: High circulating miR-21 levels
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: High circulating miR-29a levels
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Low circulating miR-126 levels
Number of subjects: 345
Study: 32445271

Group type: EXPERIMENTAL
Intervention: NexoBrid (NXB)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 110
Study: 35177133

Group type: EXPERIMENTAL
Intervention: Video-Modelling (VM)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Remote Telementoring (RTM)
Number of subjects: 24
Study: 34537805

Group type: EXPERIMENTAL
Intervention: Mother recording group
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Stranger recording group
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 34761694

Group type: EXPERIMENTAL
Intervention: Temporary percutaneous peripheral nerve stimulation (PNS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard medical therapy alone
Number of subjects: 16
Study: 33705917

Group type: EXPERIMENTAL
Intervention: Observation
Number of subjects: 111
Study: 32197594

Group type: EXPERIMENTAL
Intervention: Teaching puberty health concepts based on the health belief model (HBM) during eight 45-min sessions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional lecturing method (Control)
Number of subjects: 60
Study: 34756997

Group type: EXPERIMENTAL
Intervention: Subgluteal sciatic nerve block (SSNB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fentanyl (control)
Number of subjects: 60
Study: 34333820

Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg liquid (extracted from capsules)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Enzalutamide 40 mg liquid-filled soft-gelatin capsules (commercially available)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 1
Study: 34872042

Group type: EXPERIMENTAL
Intervention: Advice and blood flow restriction training (BFRT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Advice and traditional high intensity training (HIT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Advice only (control)
Number of subjects: 59
Study: 34221381

Group type: EXPERIMENTAL
Intervention: Pioglitazone 15 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 34963639

Group type: EXPERIMENTAL
Intervention: Co-Administered RZV and PCV13 (N=449)
Number of subjects: 912

Group type: COMPARATOR
Intervention: Control group (sequential administration of PCV13 and RZV) (N=463)
Number of subjects: 912
Study: 33554037

Group type: EXPERIMENTAL
Intervention: Web-based intervention incorporating personalized breast cancer risk, information on chemoprevention, and values clarification on chemoprevention uptake
Number of subjects: 995

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 995

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 995
Study: 35714910

Group type: EXPERIMENTAL
Intervention: Water Up!@Home intervention (12-week intervention with water filter and curriculum)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Comparison group (water filter only)
Number of subjects: 92
Study: 33487788

Group type: EXPERIMENTAL
Intervention: Virtual Reality Videos
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Chewing Gum
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study: 34653650

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing with Affirmative Care (MI-AC)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Motivational Interviewing (MI)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: MI-AC
Number of subjects: 356

Group type: COMPARATOR
Intervention: MI
Number of subjects: 356
Study: 35235629

Group type: EXPERIMENTAL
Intervention: Mineralized bone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Deproteinized bone
Number of subjects: 50
Study: 32334955

Group type: EXPERIMENTAL
Intervention: Child restraint system education only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Child restraint system education plus behavioral skills training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower parent's level of education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older child age (4 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older child age (5 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online intervention component
Number of subjects: 0
Study: 36109862

Group type: COMPARATOR
Intervention: Measurement awareness group (N=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Measurement awareness+track/record group (N=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Combined intervention groups (measurement awareness + measurement awareness+track/record)
Number of subjects: 90
Study: 34319056

Group type: EXPERIMENTAL
Intervention: Good Enough Sex (GES) model-based sexual counseling intervention, 4 sessions of 120-190 minutes each, with 2 and 3 months follow-up
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 32767971

Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage group
Number of subjects: 116
Study: 35830361

Group type: EXPERIMENTAL
Intervention: LV unloading with the Impella CP followed by immediate reperfusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed reperfusion after 30 minutes of unloading
Number of subjects: 50
Study: 33827392

Group type: EXPERIMENTAL
Intervention: Psychological therapy for depression
Number of subjects: 12

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 12
Study: 33827478

Group type: EXPERIMENTAL
Intervention: Patient education program and nurse-led telephone follow-up for 3 months
Number of subjects: 66
Study: 32460801

Group type: EXPERIMENTAL
Intervention: 5 g HMB + 5 g creatine per day (HMB-Cr)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 5 g creatine + 5 g placebo per day (Cr)
Number of subjects: 16
Study: 33934703

Group type: EXPERIMENTAL
Intervention: Fixed GnRH antagonist protocol (ganirelix 0.25 mg/d started on day 5)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Flexible GnRH antagonist protocol (started when LH > 10 IU/L, follicle > 12 mm, or serum E2 > 600 pg/ml)
Number of subjects: 201
Study: 32141709

Group type: EXPERIMENTAL
Intervention: Mesh inlay
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Mesh kit
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard (native tissue) repair
Number of subjects: 55
Study: 35460359

Group type: EXPERIMENTAL
Intervention: Nitrate (NO3‐) supplementation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 16
Study: 33059886

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification (Lifestyle)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Combination of intensive lifestyle modification and oral contraceptive pills (Combined)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Oral contraceptive pills (OCP)
Number of subjects: 114
Study: 35407483

Group type: EXPERIMENTAL
Intervention: Perceptual Learning (PL) combined with patching
Number of subjects: 25

Group type: COMPARATOR
Intervention: Patching only
Number of subjects: 25
Study: 35238148

Group type: EXPERIMENTAL
Intervention: Topical ascorbic acid (AA) application
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo formulation
Number of subjects: 25
Study: 33422621

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) using Samsung GearVR headset and AppliedVR software during the procedure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no VR)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 40
Study: 32790792

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 32432491

Group type: EXPERIMENTAL
Intervention: Preoperative opioid counseling
Number of subjects: 131

Group type: COMPARATOR
Intervention: No counseling (Control)
Number of subjects: 131
Study: 32990349

Group type: EXPERIMENTAL
Intervention: Rotating antibiotics for 6 weeks in conjunction with darifenacin for 6 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo for 6 weeks in conjunction with darifenacin for 6 months
Number of subjects: 36
Study: 33442930

Group type: EXPERIMENTAL
Intervention: High-power short-duration pulmonary vein isolation using a specialized irrigated radiofrequency ablation catheter (QDOT) at 50 W with a target Ablation Index of 350 at posterior wall.
Number of subjects: 31
Study: 32458352

Group type: EXPERIMENTAL
Intervention: Toggenburg bucks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saanen bucks
Number of subjects: 0
Study: 36216304

Group type: EXPERIMENTAL
Intervention: Calcitriol 0.25 μg once daily
Number of subjects: 127
Study: 36149628

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 158

Group type: COMPARATOR
Intervention: Combined intracervical foley's catheter plus intravenous oxytocin infusion
Number of subjects: 158
Study: 32560544

Group type: EXPERIMENTAL
Intervention: Active breaks (AB) intervention for 14 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16
Study: 36070433

Group type: EXPERIMENTAL
Intervention: Maitake D-Fraction (4 capsules, 3 times a day, taken orally before meals)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Maitake D-Fraction
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141